PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNang Kuang Pharmaceutical
Nang Kuang Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
IbandronateIbandronate2021-06-16
Postmenopausal osteoporosis
IcatibantIcatibant2020-12-16
Hereditary angioedemas
LinezolidLinezolid2016-12-20
Bacterial infections
,
Bacterial skin diseases
,
Soft tissue infections
,
Streptococcal infections
,
Bacterial pneumonia
,
Staphylococcal infections
PemetrexedPemetrexed2022-05-252035
Non-small-cell lung carcinoma,
Mesothelioma,
Mesothelial neoplasms
BendamustineBendamustine2023-06-072026-2042
Non-hodgkin lymphoma,
Lymphoid leukemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Transplatin
carcinoma
,
esophageal neoplasms
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
Esmirtazapine
pain
,
depression
,
depressive disorder
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use